In one of our ongoing global studies in Lupus, our SMO once again enrolled the highest number of patients worldwide! Both of our Polish sites – in Bydgoszcz and Warsaw – became top-enrolling locations, outperforming sites from China, Spain, Bulgaria, the United States, and Taiwan.
Our recruitment and pre-screening processes were recognized by the study sponsor:
“Your dedication to the study is truly remarkable, and we sincerely appreciate your hard work.”
As one of our principal investigators shared, there is no secret behind this repeated success:
“The key is maintaining a close relationship with patients, so they feel comfortable and motivated to participate in a clinical trial. It’s a matter of trust. The investigator’s engagement is essential – patients need to feel appreciated.”
We are truly grateful for the opportunity to contribute to this important project. Congratulations to both teams for yet another outstanding achievement!
Check out our previous enrollment success in Lupus studies:
